QGEN Qiagen N.V.

NYSE · US · Healthcare · Diagnostics & Research · qiagen.com

44.79USD-1.88%Mkt Cap: 9.25B $P/E: 22.741d ago

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification …

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc.

Agilent Technologies, Inc.

IDEXX Laboratories, Inc.

$39.97BUSDP/E 35.6

MTD

Mettler-Toledo International Inc.

$30.73BUSDP/E 34.6

Labcorp Holdings Inc.

$25.30BUSDP/E 25.8

DGX

Quest Diagnostics Incorporated

$25.06BUSDP/E 24.1

Guardant Health, Inc.

Medpace Holdings, Inc.

$16.87BUSDP/E 35.5

ERF

Eurofins Scientific SE

$14.23BUSDP/E 26.6

CRL

Charles River Laboratories International, Inc.

$14.34BUSD

ICLR

ICON Public Limited Company

Key Statistics

Company

Market Cap9.25B USD

Enterprise Value10.29B USD

Revenue (TTM)2.10B USD

Gross Profit1.30B USD

Net Income (TTM)424.88M USD

Revenue/Share10.16 USD

Last Price44.79 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees5.5K

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)22.74

P/E (Forward)17.47

PEG1.22

EV/EBITDA14.01

EV/Revenue4.90

P/S4.49

P/B2.81

EPS (TTM)1.97

EPS (Forward)2.61

52W Range

32.5348% of range57.82

52W High57.82 USD

52W Low32.53 USD

Profitability

Gross Margin62.18%

Oper. Margin26.32%

EBITDA Margin34.96%

Profit Margin20.33%

ROE11.25%

ROA6.76%

Growth

Revenue Growth0.30%

Earnings Growth7.90%

Cash Flow & Leverage

Operating CF654.33M USD

CapEx (TTM)207.13M USD

FCF Margin17.75%

FCF Yield4.03%

Net Debt860.20M USD

Net Debt/EBITDA1.17

Balance Sheet

Debt/Equity0.48

Current Ratio2.85

Quick Ratio2.05

Book Value/Sh16.26 USD

Cash/Share3.84 USD

Dividends

Fwd Div Rate0.35 USD

Trail. Div Rate0.36 USD

Div. Yield0.76%

5Y Avg Yield—

Payout Ratio17.79%

Ex-Div DateJul 7, 2026

Pay DateJul 14, 2026

Splits

Last Split962:1000

Split DateJan 25, 2017

Analyst Consensus

Rating2.3 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)47.27 USD

Upside (mean)+5.5%

Target Range40.00 USD – 55.00 USD

40.00+5.5% to mean55.00

# Analysts15

Ownership

Shares Out.206.50M

Float205.13M

Insiders0.48%

Institutions79.29%

Short Interest

Short Ratio3.0d

Short % Float4.20%

Short % Out.3.71%

Shares Short7.66M

Short (prev mo.)10.14M

Technical

SMA 5043.15 (+3.8%)

SMA 20042.46 (+5.5%)

Beta0.61

S&P 52W Chg15.78%

Avg Vol (30d)2.07M

Avg Vol (10d)2.71M

Technical Indicators

RSI (14)54.2

MACD0.5322

MACD Signal0.4269

MACD Hist.+0.1053

BB Upper46.23 USD

BB Middle43.84 USD

BB Lower41.45 USD

BB Width10.91%

ATR (14)1.428 USD

Vol Ratio (20d)1.17x